United States · FDA National Drug Code directory
dextroamphetamine sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45963-303_efcdbc4d-7174-4356-9aa2-d557735e2048
- Product NDC
- 45963-303
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- dextroamphetamine sulfate
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140619
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SULFATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-303-09) · 45963-303-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →